Actively Recruiting
Effectiveness of Self-posturotherapy on the Elimination of Residual Fragments After Treatment of Lower Calyx Urinary Stones by Extracorporeal Lithotripsy or Retrograde Flexible Ureteroscopy.
Led by GCS Ramsay Santé pour l'Enseignement et la Recherche · Updated on 2025-07-08
216
Participants Needed
2
Research Sites
95 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective of this study is to evaluate the effectiveness of an auto posturotherapy technique on the RFS at three months of patients treated for lower calyceal urinary stones by extracorporeal lithotripsy (ECL) or retrograde flexible ureteroscopy.
CONDITIONS
Official Title
Effectiveness of Self-posturotherapy on the Elimination of Residual Fragments After Treatment of Lower Calyx Urinary Stones by Extracorporeal Lithotripsy or Retrograde Flexible Ureteroscopy.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient has read and signed the consent form to participate in the study
- Candidate for treatment of a lower calyx stone smaller than 15 mm by extracorporeal lithotripsy (LEC) or retrograde flexible ureteroscopy (URSS)
- Treated by LEC or URSS with observed lower calyceal stone fragments by endoscopy
- No JJ stent currently in place (patients with stents can participate once removed)
You will not qualify if you...
- Presence of kidney or ureter malformations such as ureteral stenosis, pyelo-ureteral junction syndrome, horseshoe kidney, para calyceal diverticulum, or pelvic kidney
- Interrupted LEC session due to treatment intolerance
- Physical disability preventing posturotherapy (including spinal issues), morbid obesity, severe gastroesophageal reflux, heart or respiratory failure
- Balance disorders preventing self-posturotherapy
- Legal protection status such as guardianship or curatorship
- Posturotherapy done while wearing a JJ probe
- Posturotherapy performed by someone else (e.g., physiotherapist)
- Pregnant or breastfeeding
- Not affiliated with the French social security system
- Unable to provide informed consent due to dementia, psychosis, consciousness disorders, or not speaking French
- Taking treatments that may affect stone fragment clearance (e.g., beta blockers, diuretics)
- Participation in another therapeutic study protocol
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Hôpital Edouard Herriot -
Lyon, France, 69003
Actively Recruiting
2
Clinique La Croix du Sud
Quint-Fonsegrives, France, 31130
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here